Eli Lilly and Company LLY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use ...

Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic ...

Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...

Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...

(RTTNews) - Eli Lilly and Company (LLY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for Jaypirca, a non-covalent ...

"Unsurprisingly, pirtobrutinib [Jaypirca, Eli Lilly & Co.] was superior to the comparator arm in terms of progression-free survival," Woyach, professor in the division of hematology at The Ohio ...

which generally follows the CHMP's advice, is expected to make a final decision in the next one to two months. Eli Lilly previously won conditional European approval for Jaypirca in adults with ...